MREO — Mereo BioPharma Group plc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1719714 ·
United Kingdom
Last close
$0.27
Market Cap
$43.84M
52W High
$2.37
52W Low
$0.20
ADV30
760,412
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 800,000 | 800,000 | -6,121,000 | -5,863,000 | 29,583,000 | 26,097,000 | 5,872,000 |
| Jun 2026 | 0 | 0 | -6,911,000 | -7,005,000 | 34,714,000 | 30,118,000 | 6,062,000 |
| Mar 2026 | 0 | — | -8,671,000 | -6,719,000 | 40,614,000 | 36,223,000 | 6,560,000 |
| Dec 2025 | 0 | 0 | -7,917,000 | -7,351,000 | 45,917,000 | 40,992,000 | 5,001,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-22,088,000
Investing CF
$-300,000
Financing CF
$39,000
CapEx
$-620,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.20
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-520,406,000
Inventory
—
Receivables
$615,000
ST Investments
—
EBIT TTM
$-26,869,000
Pretax Income TTM
$-26,938,000
Interest Exp TTM
$69,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$800,000
EBITDA
$-28,665,000
Free Cash Flow
$-9,223,250
Enterprise Value
$23,587,946
Total Cash
$26,097,000
Total Debt
$577,000
Shares Out
159,700,637
Trailing EPS
$-0.15
Book Value
$0.15
ROE
-76.6%
ROA
-44.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 500,000 | -38,257,000 | -41,878,000 | 45,917,000 | 5,001,000 | 40,916,000 | -30,971,000 |
| Dec 2024 | 0 | -45,715,000 | -43,253,000 | 76,390,000 | 15,421,000 | 60,969,000 | -32,834,000 |
| Dec 2023 | 10,000,000 | -27,136,000 | -29,466,000 | 66,499,000 | 15,962,000 | 50,537,000 | -21,132,000 |
| Dec 2022 | 0 | -52,698,000 | -42,220,000 | 77,413,000 | 26,011,000 | 51,402,000 | -48,821,000 |
TTM Snapshot
Revenues TTM
$-332,000
NetIncome TTM
$-28,099,000
OpCashFlow TTM
—
Assets (Latest)
$34,714,000
Forward EPS
$-0.02
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $0.50 · spot: $0.29 · call volume: 202 · put volume: 10
Expected Move to 2027-01-15:
±$0.22
(76.12%) —
implied range
$0.07 –
$0.51
· ATM straddle on $0.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PRNAF | ALTERITY THERAPEUTICS LTD | $43.70M | $0.20 | — |
| HYFT | MindWalk Holdings Corp. | $42.60M | $0.91 | — |
| ATNM | Actinium Pharmaceuticals, Inc. | $42.45M | $1.35 | — |
| ALDX | Aldeyra Therapeutics, Inc. | $41.88M | $0.69 | — |
| SMNR | Semnur Pharmaceuticals, Inc. | $46.04M | $0.20 | — |
News headlines (Yahoo Finance, 1h cache)
Mereo BioPharma Reports Third Quarter 2026 Financial Results
2026-11-09 13:00 · Yahoo
Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights
2026-08-11 12:15 · Yahoo
Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
2026-08-11 12:00 · Yahoo
Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
2026-08-11 12:00 · Yahoo
European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading
2026-06-15 15:09 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
2026-06-02 15:08 · Yahoo
Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
2026-05-12 11:30 · Yahoo
We're Hopeful That Mereo BioPharma Group (NASDAQ:MREO) Will Use Its Cash Wisely
2026-04-07 13:39 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
2026-04-02 15:09 · Yahoo
European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading
2026-02-24 16:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.